Literature DB >> 26836787

HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks.

Don C Des Jarlais1, Thomas Kerr, Patrizia Carrieri, Jonathan Feelemyer, Kamyar Arasteh.   

Abstract

AIDS among persons who inject drugs, first identified in December 1981, has become a global epidemic. Injecting drug use has been reported in 148 countries and HIV infection has been seen among persons who inject drugs in 61 countries. Many locations have experienced outbreaks of HIV infection among persons who inject drugs, under specific conditions that promote very rapid spread of the virus. In response to these HIV outbreaks, specific interventions for persons who inject drugs include needle/syringe exchange programs, medicated-assisted treatment (with methadone or buprenorphine) and antiretroviral therapy. Through a 'combined prevention' approach, these interventions significantly reduced new HIV infections among persons who inject drugs in several locations including New York City, Vancouver and France. The efforts effectively ended the HIV epidemic among persons who inject drugs in those locations. This review examines possible processes through which combined prevention programs may lead to ending HIV epidemics. However, notable outbreaks of HIV among persons who inject drugs have recently occurred in several countries, including in Athens, Greece; Tel-Aviv, Israel; Dublin, Ireland; as well as in Scott County, Indiana, USA. This review also considers different factors that may have led to these outbreaks. We conclude with addressing the remaining challenges for reducing HIV infection among persons who inject drugs.

Entities:  

Mesh:

Year:  2016        PMID: 26836787      PMCID: PMC4785082          DOI: 10.1097/QAD.0000000000001039

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  49 in total

1.  A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India.

Authors:  A D Eicher; N Crofts; S Benjamin; P Deutschmann; A J Rodger
Journal:  AIDS Care       Date:  2000-08

2.  International epidemiology of HIV and AIDS among injecting drug users.

Authors:  D C Des Jarlais; S R Friedman; K Choopanya; S Vanichseni; T P Ward
Journal:  AIDS       Date:  1992-10       Impact factor: 4.177

3.  Prevalence and characteristics of individuals with undiagnosed HIV infection in France: evidence from a survey on hepatitis B and C seroprevalence.

Authors:  Françoise Cazein; Francis Barin; Yann Le Strat; Josiane Pillonel; Stephane Le Vu; Florence Lot; Damien Thierry; Christine Meffre; Caroline Semaille
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

Review 4.  HIV prevention for injecting drug users: the first 25 years and counting.

Authors:  Don C Des Jarlais; Salaam Semaan
Journal:  Psychosom Med       Date:  2008-06-02       Impact factor: 4.312

Review 5.  HIV infection among intravenous drug users: epidemiology and risk reduction.

Authors:  D C Des Jarlais; S R Friedman
Journal:  AIDS       Date:  1987-07       Impact factor: 4.177

6.  Factors associated with HIV seropositivity in European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users.

Authors:  C Richardson; R Ancelle-Park; G Papaevangelou
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

7.  The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.

Authors:  Perrine Roux; M Patrizia Carrieri; Virgine Villes; Pierre Dellamonica; Isabelle Poizot-Martin; Isabelle Ravaux; Bruno Spire
Journal:  Addiction       Date:  2008-09-04       Impact factor: 6.526

8.  Injection of new psychoactive substance snow blow associated with recently acquired HIV infections among homeless people who inject drugs in Dublin, Ireland, 2015.

Authors:  Coralie Giese; Derval Igoe; Zorina Gibbons; Caroline Hurley; Siobhan Stokes; Sinead McNamara; Orla Ennis; Kate O'Donnell; Eamon Keenan; Cillian De Gascun; Fiona Lyons; Mary Ward; Kostas Danis; Ronan Glynn; Allison Waters; Margaret Fitzgerald
Journal:  Euro Surveill       Date:  2015

Review 9.  Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research.

Authors:  Elaine Hyshka; Steffanie Strathdee; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2012-05-11

10.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

Authors:  Charlotte Van Den Berg; Colette Smit; Giel Van Brussel; Roel Coutinho; Maria Prins
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

View more
  50 in total

1.  Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.

Authors:  Vana Sypsa; Mina Psichogiou; Dimitrios Paraskevis; Georgios Nikolopoulos; Chrissa Tsiara; Dimitra Paraskeva; Katerina Micha; Meni Malliori; Anastasia Pharris; Lucas Wiessing; Martin Donoghoe; Samuel Friedman; Don Des Jarlais; Georgios Daikos; Angelos Hatzakis
Journal:  J Infect Dis       Date:  2017-05-15       Impact factor: 5.226

2.  Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

Authors:  Roman Shrestha; Frederick L Altice; Brian Sibilio; Jude Ssenyonjo; Michael M Copenhaver
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

3.  HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks: authors' reply.

Authors:  Don C Des Jarlais; Patrizia Carrieri
Journal:  AIDS       Date:  2016-07-17       Impact factor: 4.177

4.  Trends in HIV Infection Among Persons Who Inject Drugs: United States and Puerto Rico, 2008-2013.

Authors:  Andrew John Mitsch; H Irene Hall; Aruna Surendera Babu
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

5.  Acute HIV infection transmission among people who inject drugs in a mature epidemic setting.

Authors:  Daniel J Escudero; Mark N Lurie; Kenneth H Mayer; Caleb Weinreb; Maximilian King; Sandro Galea; Samuel R Friedman; Brandon D L Marshall
Journal:  AIDS       Date:  2016-10-23       Impact factor: 4.177

Review 6.  Substance Use and Adherence to Antiretroviral Therapy: What Is Known and What Is Unknown.

Authors:  M Eugenia Socias; M-J Milloy
Journal:  Curr Infect Dis Rep       Date:  2018-07-31       Impact factor: 3.725

7.  Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.

Authors:  E Jennifer Edelman; Brent A Moore; Sarah K Calabrese; Gail Berkenblit; Chinazo Cunningham; Viraj Patel; Karran Phillips; Jeanette M Tetrault; Minesh Shah; David A Fiellin; Oni Blackstock
Journal:  AIDS Behav       Date:  2017-04

8.  Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement.

Authors:  Ali Mirzazadeh; Jennifer L Evans; Judith A Hahn; Jennifer Jain; Alya Briceno; Stephen Shiboski; Paula J Lum; Christopher Bentsen; Geoff Davis; Kathy Shriver; Melanie Dimapasoc; Mars Stone; Michael P Busch; Kimberly Page
Journal:  AIDS Behav       Date:  2018-04

9.  State Laws Governing Syringe Services Programs and Participant Syringe Possession, 2014-2019.

Authors:  Marcelo H Fernández-Viña; Nadya E Prood; Adam Herpolsheimer; Joshua Waimberg; Scott Burris
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

10.  Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis.

Authors:  Manon Ragonnet-Cronin; Celia Jackson; Amanda Bradley-Stewart; Celia Aitken; Andrew McAuley; Norah Palmateer; Rory Gunson; David Goldberg; Catriona Milosevic; Andrew J Leigh Brown
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.